Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency of TERT promoter mutations in human cancers.
Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P. Vinagre J, et al. Nat Commun. 2013;4:2185. doi: 10.1038/ncomms3185. Nat Commun. 2013. PMID: 23887589 Free article.
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P. Melo M, et al. J Clin Endocrinol Metab. 2014 May;99(5):E754-65. doi: 10.1210/jc.2013-3734. Epub 2014 Jan 29. J Clin Endocrinol Metab. 2014. PMID: 24476079 Free PMC article.
TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation.
Pópulo H, Boaventura P, Vinagre J, Batista R, Mendes A, Caldas R, Pardal J, Azevedo F, Honavar M, Guimarães I, Manuel Lopes J, Sobrinho-Simões M, Soares P. Pópulo H, et al. J Invest Dermatol. 2014 Aug;134(8):2251-2257. doi: 10.1038/jid.2014.163. Epub 2014 Apr 1. J Invest Dermatol. 2014. PMID: 24691053 Free article.
mTOR activation in medullary thyroid carcinoma with RAS mutation.
Lyra J, Vinagre J, Batista R, Pinto V, Prazeres H, Rodrigues F, Eloy C, Sobrinho-Simões M, Soares P. Lyra J, et al. Eur J Endocrinol. 2014 Nov;171(5):633-40. doi: 10.1530/EJE-14-0389. Epub 2014 Aug 27. Eur J Endocrinol. 2014. PMID: 25163725
The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC, Menezes W, Becker AP, de Almeida GC, Matsushita MM, Clara C, Neder L, Viana-Pereira M, Honavar M, Castro L, Lopes JM, Carvalho B, Vaz RM, Máximo V, Soares P, Sobrinho-Simões M, Reis RM, Lima J. Batista R, et al. Int J Cancer. 2016 Jul 15;139(2):414-23. doi: 10.1002/ijc.30057. Epub 2016 Mar 24. Int J Cancer. 2016. PMID: 26914704 Free article.
pmTOR is a marker of aggressiveness in papillary thyroid carcinomas.
Tavares C, Coelho MJ, Melo M, da Rocha AG, Pestana A, Batista R, Salgado C, Eloy C, Ferreira L, Rios E, Sobrinho-Simões M, Soares P. Tavares C, et al. Surgery. 2016 Dec;160(6):1582-1590. doi: 10.1016/j.surg.2016.06.050. Epub 2016 Aug 26. Surgery. 2016. PMID: 27574774
32 results